[HTML][HTML] NSAIDs and COVID-19: a systematic review and meta-analysis

N Moore, P Bosco-Levy, N Thurin, P Blin… - Drug safety, 2021 - Springer
Background Nonsteroidal anti-inflammatory drugs (NSAIDs) have been discouraged for the
treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections …

[HTML][HTML] Use of non-steroidal anti-inflammatory drugs and adverse outcomes during the COVID-19 pandemic: A systematic review and meta-analysis

Q Zhou, S Zhao, L Gan, Z Wang, S Peng, Q Li… - …, 2022 - thelancet.com
Background There are concerns that the use of non-steroidal anti-inflammatory drugs
(NSAIDs) may increase the risk of adverse outcomes among patients with coronavirus …

Drug safety of frequently used drugs and substances for self-medication in COVID-19

D Baracaldo-Santamaría… - … advances in drug …, 2022 - journals.sagepub.com
During the COVID-19 pandemic, the behavior of self-medication has increased. The
dissemination of misleading information regarding the efficacy of certain drugs or …

[HTML][HTML] Platelets in viral infections–brave soldiers or Trojan horses

WC Schrottmaier, A Schmuckenschlager… - Frontiers in …, 2022 - frontiersin.org
Viral infections are often associated with platelet activation and haemostatic complications.
In line, low platelet counts represent a hallmark for poor prognosis in many infectious …

[HTML][HTML] Does aspirin have an effect on risk of death in patients with COVID-19? A meta-analysis

S Ma, W Su, C Sun, S Lowe, Z Zhou, H Liu… - European Journal of …, 2022 - Springer
Purpose The coronavirus disease 2019 (COVID-19) pandemic has shown unprecedented
impact world-wide since the eruption in late 2019. Importantly, emerging reports suggest an …

[HTML][HTML] NSAID use and clinical outcomes in COVID-19 patients: a 38-center retrospective cohort study

JT Reese, B Coleman, L Chan, H Blau, TJ Callahan… - Virology journal, 2022 - Springer
Background Non-steroidal anti-inflammatory drugs (NSAIDs) are commonly used to reduce
pain, fever, and inflammation but have been associated with complications in community …

[HTML][HTML] Cerebrovascular manifestations of SARS-CoV-2: a comprehensive review

Ε Stefanou, N Karvelas, S Bennett, C Kole - Current Treatment Options in …, 2023 - Springer
Purpose of review The risks of cerebrovascular manifestations due to SARS-CoV-2 infection
are significantly increased within the first 6 months of the infection. Our work aims to give an …

[HTML][HTML] Aspirin in COVID-19: Pros and cons

R Zareef, M Diab, T Al Saleh, A Makarem… - Frontiers in …, 2022 - frontiersin.org
Since its emergence, the COVID-19 pandemic has been ravaging the medical and
economic sectors even with the significant vaccination advances. In severe presentations …

[HTML][HTML] Arterial thrombotic events in hospitalized COVID-19 patients: a short review and meta-analysis

M Candeloro, S Schulman - Seminars in Thrombosis and …, 2023 - thieme-connect.com
It is well established that the risk of venous thromboembolism is high in coronavirus disease
19 (COVID-19). The frequency of arterial thromboembolic events (ATEs) in hospitalized …

Prescription for COVID-19 by non-medical professionals during the pandemic in Colombia: a cross-sectional study

MJ Nino-Orrego… - … Advances in Drug …, 2022 - journals.sagepub.com
Background: The COVID-19 pandemic has led to an increase in the behavior of self-
medication (SM). Given the massive release of misleading information during the pandemic …